Showing results (21-30 of 61) with videos related to
Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2002
Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccineEddy C Hsueh, Richard Essner, Leland J Foshag, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapySteven J O'Day, Peter D Boasberg, Lawrence Piro, et al.The Journal of Investigative Dermatology|September 2, 2006
Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanomaPeter D Boasberg, Dave S B Hoon, Lawrence D Piro, et al.BMC Cancer|August 1, 2009
Phase II assessment of talabostat and cisplatin in second-line stage IV melanomaRobert M Eager, C Casey Cunningham, Neil N Senzer, et al.Cancer Immunity|October 21, 2010
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trialsJedd D Wolchok, Jeffrey S Weber, Omid Hamid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trialKazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.Investigational New Drugs|January 19, 2010
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanomaEvan M Hersh, Steven J O'Day, John Powderly, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2009
Phase II multicenter trial of maintenance biotherapy after induction concurrent Biochemotherapy for patients with metastatic melanomaSteven J O'Day, Michael B Atkins, Peter Boasberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2006
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patientsKazuo Koyanagi, Steven J O'Day, Rene Gonzalez, et al.Cancer Research|July 5, 2006
Estrogen receptor-alpha methylation predicts melanoma progressionTakuji Mori, Steve R Martinez, Steven J O'Day, et al.Pageof 7